This website is dedicated to the millions of thyroid patients who are being ignored and left to suffer unnecessarily, and to healthcare practitioners, who want to better serve those patients.

Influences On Practice

Influences On Practice

Powered by Ajaxy

Applying a systems approach to thyroid physiology

07 Jul 2017

Applying a systems approach to thyroid physiology: Looking at the whole with a mitochondrial perspective…

The Diagnosis and Treatment of Hypothyroidism: A Patient’s Perspective

28 Jul 2016

Three authors, Mel Rowe, Rudolf Hoermann and Peter Warmingham have published a 42 page article,…

TPA rebuts statement by PrescQIPP that T3 “….is of limited value and may be harmful…”

02 Jun 2016

Charity Registration Number 1138608 TPA’s REBUTTAL to PRESCQIPP – BULLETIN 121- LIOTHYRONINE https://www.prescqipp.info/drop-list/send/52-drop-list/2047-bulletin-117-drop-list   INTRODUCTION:…

Rethinking the TSH Test and why the TSH test needs to be abandoned!

18 Feb 2016

Rethinking the TSH Test: An Interview with David Derry, M.D., Ph.D. The History of Thyroid…

Has Your Get Up and Go Got Up and Gone?

28 Jan 2016

Are you tired of hearing that “nothing else can be done for you?” Are you…

British Science Needs Integrity Overhaul

25 Jan 2016

British Science Needs Integrity Overhaul. Because of the widespread dissatisfaction by hundreds of thousands of…

Dr Anthony Toft Response Thyroiditis, Thyroid Eye Disease and Thyroxine Dosing

21 Mar 2014

1st June 2010Endocrinologist Dr Anthony Toft answers GP Dr Pam Browns questions on thyroiditis, thyroid…

Quote – by Dr Jacob Teitelbaum – Testing for Thyroid Disease!

03 Mar 2014

“Many years ago, while I was in medical school, physicians were taught to diagnose hypothyroidism,…

Following the Script: How Drug Reps Make Friends and Influence Doctors

18 Jan 2014

In 2000, pharmaceutical companies spent more than 15.7 billion dollars on promoting prescription drugs in…

Coralie Phillips and Donna Roach Letter to the United States Food and Drug Administration (FDA)

18 Jan 2014

druginfo@fda.hhs.govcderombudsman@fda.hhs.gov CDER OMBUDSMANWHITE OAK BUILDING 51ROOM 615810903 NEW HAMPSHIRE AVENUESILVER SPRING, MD 20993USA TEL: 001…